Sort
23,748 grants matching “melanoma”
SOUTHWEST ONCOLOGY GROUP
$349,263Swedish Medical Center, First Hill · U10 · FY2000 · CA
Cell Cycle Check Points
$349,200William K Kaufmann · Univ Of North Carolina Chapel Hill · P01 · FY2009 · ES
DNA sensors and associated signaling pathways in the innate immune response
$349,100Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · AI
DNA sensors and associated signaling pathways in the innate immune response
$349,100Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · AI
DNA sensors and associated signaling pathways in the innate immune response
$349,100Katherine A Fitzgerald · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · AI
Translation of commensal bacteria mechanism for immunotherapy
$349,038Howard C Hang · Scripps Research Institute, The · R01 · FY2021 · CA
Structure and Function of T Cell Antigen Receptors
$348,975Roy A Mariuzza · Univ Of Maryland, College Park · R01 · FY2013 · AI
Mitochondrial lateral transfer during metastasis
$348,844Minna Roh · Utah State Higher Education System--University Of Utah · R37 · FY2025 · CA
COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY
$348,844David G Denardo · Washington University · R01 · FY2020 · CA
COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY
$348,844David G Denardo · Washington University · R01 · FY2016 · CA
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression
$348,844Robert Laird Judson-Torres · University Of Utah · R01 · FY2021 · CA
Targeting Rheostatic Mechanisms of Melanoma Progression
$348,844Allie H. Grossmann · University Of Utah · R37 · FY2021 · CA
Targeting Rheostatic Mechanisms of Melanoma Progression
$348,844Allie H. Grossmann · University Of Utah · R37 · FY2020 · CA
Mitochondrial lateral transfer during metastasis
$348,844Minna Roh · University Of Utah · R37 · FY2021 · CA
COMBINED TUMOR AND STROMAL TARGETING TO IMPROVE PANCREATIC CANCER RESPONSE TO IMMUNOTHERAPY
$348,844David G Denardo · Washington University · R01 · FY2017 · CA
Mitochondrial lateral transfer during metastasis
$348,844Minna Roh · University Of Utah · R37 · FY2022 · CA
Targeting Rheostatic Mechanisms of Melanoma Progression
$348,844Allie H. Grossmann · University Of Utah · R37 · FY2022 · CA
Nevus associated microRNAs as mediators of BRAF-induced growth arrest and biomarkers of melanoma progression
$348,844Robert Laird Judson-Torres · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL
$348,844Michael W Deininger · University Of Utah · R01 · FY2021 · CA
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$348,835Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2021 · CA
Mechanisms of selective therapeutic synergy of PARP-inhibition and CTLA4 blockade engaged by interferon-gamma in the ovarian tumor microenvironment
$348,832Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2020 · CA
Melanoma immunotherapy targeting sentinel lymph nodes
$348,780Susan Napier Thomas · Georgia Institute Of Technology · R01 · FY2019 · CA
Targeting antigen presentation to improve immunotherapy responses in breast cancer
$348,754Justin M Balko · Vanderbilt University Medical Center · P50 · FY2020 · CA
Optimizing systemic immunotherapy for personalized brain metastasis treatment
$348,747Michael Lim · Stanford University · U54 · FY2025 · CA
Immunobiology of Pediatric Tumors
$348,659Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA